UNTREATED GRAVES-DISEASE PATIENTS WITHOUT CLINICAL OPHTHALMOPATHY DEMONSTRATE A HIGH-FREQUENCY OF EXTRAOCULAR-MUSCLE (EOM) ENLARGEMENT BY MAGNETIC-RESONANCE

被引:77
作者
VILLADOLID, MC [1 ]
YOKOYAMA, N [1 ]
IZUMI, M [1 ]
NISHIKAWA, T [1 ]
KIMURA, H [1 ]
ASHIZAWA, K [1 ]
KIRIYAMA, T [1 ]
UETANI, M [1 ]
NAGATAKI, S [1 ]
机构
[1] NAGASAKI UNIV, SCH MED, DEPT RADIOL, NAGASAKI 852, JAPAN
关键词
D O I
10.1210/jc.80.9.2830
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
12 of 17, a significant frequency (71%), of untreated Graves' disease patients with no clinical ophthalmopathy showed extraocular muscle (EOM) enlargement by Magnetic Resonance Imaging (MRI). Enlargement was bilateral in 41% and unilateral in 29% in these patients. Apparent enlargements of EOM were also detected, by MRI, in all of 11 Graves' disease patients with clinical ophthalmopathy, bilateral in 73% and unilateral in 27% of patients in this group. Both group showed the inferior rectus muscle as the most frequently involved (56% and 77% respectively). In 16 patients without autoimmune thyroid disorders or ophthalmopathy who served as normal controls, only 2 of these patients (12%) demonstrated mild EOM enlargement. The severity and patterns of EOM enlargement revealed no correlation with abnormalities in serum thyroid function tests or serum thyroidal autoantibodies. In conclusion, a high frequency of Graves' disease patients without clinical eye signs or symptoms harbor EOM abnormalities, as demonstrated by MRI. This suggests that present clinical examination methods are insufficient to diagnose varying degrees of ophthalmopathy in patients with autoimmune thyroid disorders who do not initially present with clinical ophthalmopathy.
引用
收藏
页码:2830 / 2833
页数:4
相关论文
共 20 条
[1]   EXOPHTHALMOS IN AUTOIMMUNE THYROID-DISEASE [J].
AMINO, N ;
YUASA, T ;
YABU, Y ;
MIYAI, K ;
KUMAHARA, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (06) :1232-1234
[2]  
ATKINSON S, 1984, LANCET, V2, P374
[3]   USE OF CORTICOSTEROIDS TO PREVENT PROGRESSION OF GRAVES OPHTHALMOPATHY AFTER RADIOIODINE THERAPY FOR HYPERTHYROIDISM [J].
BARTALENA, L ;
MARCOCCI, C ;
BOGAZZI, F ;
PANICUCCI, M ;
LEPRI, A ;
PINCHERA, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (20) :1349-1352
[4]  
BECK RW, 1990, NEW ENGL J MED, V332, P1088
[5]   ANTIBODIES AGAINST D-1, A RECOMBINANT 64-KDA MEMBRANE-PROTEIN, ARE ASSOCIATED WITH OPHTHALMOPATHY IN PATIENTS WITH THYROID AUTOIMMUNITY [J].
BERNARD, NF ;
NYGEN, TN ;
TYUTYUNIKOV, A ;
STOLARSKI, C ;
SCALISE, D ;
GENOVESE, C ;
HAYES, MB ;
LUDGATE, M ;
WALL, JR .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 70 (03) :225-233
[6]   THE EVOLUTION OF GRAVES OPHTHALMOPATHY DURING TREATMENT WITH ANTITHYROID DRUG ALONE AND COMBINED WITH TRIIODOTHYRONINE [J].
BROMBERG, N ;
ROMALDINI, JH ;
WERNER, RS ;
SGARBI, JA ;
WERNER, MC .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1992, 15 (03) :191-195
[7]  
ENZMANN DR, 1979, J COMPUT ASSIST TOMO, V3, P815
[8]   CLINICAL-SIGNIFICANCE OF EXTRA-OCULAR MUSCLE VOLUMES IN GRAVES OPHTHALMOPATHY - A QUANTITATIVE COMPUTED-TOMOGRAPHY STUDY [J].
FELDON, SE ;
WEINER, JM .
ARCHIVES OF OPHTHALMOLOGY, 1982, 100 (08) :1266-1269
[9]   EXPRESSION OF THYROTROPIN-RECEPTOR MESSENGER-RNA IN HEALTHY AND GRAVES-DISEASE RETRO-ORBITAL TISSUE [J].
FELICIELLO, A ;
PORCELLINI, A ;
CIULLO, I ;
BONAVOLONTA, G ;
AVVEDIMENTO, EV ;
FENZI, G .
LANCET, 1993, 342 (8867) :337-338
[10]  
FORBES G, 1986, AM J NEURORADIOL, V7, P651